title: Fixed drug eruptions with feprazone are linked to HLA-B22.
authors.affiliation: Department of Dermatology, IRCCS-Hospital Casa Sollievo della Sofferenza, Rotondo, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Pellicano
authors.forename: M
authors.initials: M
authors.lastname: Lomuto
authors.forename: G
authors.initials: G
authors.lastname: Ciavarella
authors.forename: G
authors.initials: G
authors.lastname: Di Giorgio
authors.forename: P
authors.initials: P
authors.lastname: Gasparini
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology / Q000235:genetics*; D011298:Feprazone / Q000009:adverse effects*; D015235:HLA-B Antigens / Q000032:analysis* / Q000235:genetics; D006801:Humans
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D015235:HLA-B Antigens; C105903:HLA-B22 antigen; D011298:Feprazone